XML 86 R75.htm IDEA: XBRL DOCUMENT v3.25.1
Note 17 - Related Parties (Details Textual) - USD ($)
3 Months Ended
Jan. 29, 2025
Jan. 06, 2025
Dec. 31, 2024
Oct. 25, 2024
Sep. 03, 2024
Aug. 28, 2024
May 01, 2024
Jan. 09, 2023
Mar. 31, 2025
Aug. 23, 2024
Aug. 22, 2024
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)                    
Class of Warrant or Right, Exercised in Period (in shares)                 939,000    
Series H Warrants [Member]                      
Class of Warrant or Right, Exercised in Period (in shares)       1,990,000              
Series I Warrants [Member]                      
Class of Warrant or Right, Exercised in Period (in shares)       2,325,000              
Non-plan Options [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)                 500,000    
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)                 $ 0.53    
Chief Commercial Officer [Member] | Non-plan Options [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) 250,000           25,000        
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share) $ 0.42           $ 5.321        
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Non-plan Options [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) 25,000                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage             20.00%        
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)             5 years        
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | Non-plan Options [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) 25,000                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year) 4 years                    
Chief Commercial Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member] | Non-plan Options [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) 31,250                    
Chief Financial Officer [Member] | Non-plan Options [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)   500,000                  
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)   $ 0.53                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)   36 months                  
Chief Financial Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Non-plan Options [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Year)   3 years                  
Old Catheter [Member] | Mr. Jenkins and Affiliates [Member]                      
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                 1,325.838    
Old Catheter [Member] | Mr. Jenkins Adult Children [Member]                      
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)                 1,284.344    
Business Combination, Consideration Transferred, Equity Interest, Share Held, Number of Shares (in shares)                 9,239.285    
David Jenkins [Member]                      
Convertible Notes Payable               $ 25,100,000      
Interest Accrued and Unpaid, Forgiven Amount               $ 13,900,000      
David Jenkins [Member] | LockeT Royalty [Member]                      
Royalty Percentage               12.00%      
David Jenkins [Member] | Conversion of Convertible Promissory Notes into Series X Preferred Stock [Member]                      
Convertible Preferred Stock, Shares Issued upon Conversion (in shares)               7,856.251      
Auston Locke [Member] | LockeT Royalty [Member]                      
Royalty Percentage               5.00%      
Royalty Guarantees, Commitments, Amount               $ 1,000,000      
Auston Locke [Member] | LockeT Royalty [Member] | Royalty Payment After U.S. Patent Granted and One Million Paid [Member]                      
Royalty Percentage               2.00%      
Royalty Guarantees, Commitments, Amount               $ 10,000,000      
Non-Executive Chief Operating Officer [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)               14,416      
Non-Executive Chief Operating Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)               14,081      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)               $ 5.9      
Non-Executive Chief Operating Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares)               335      
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in dollars per share)               $ 20.2      
Related Party [Member] | Related Party Notes [Member]                      
Debt Instrument, Interest Rate, Stated Percentage                   12.00% 8.00%
Jenkins Family Charitable Institute [Member]                      
Proceeds from Issuance Initial Public Offering         $ 500,000            
Stock Issued During Period, Shares, New Issues (in shares)         265,000            
Jenkins Family Charitable Institute [Member] | Prefunded Warrants [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)         235,000            
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)         $ 0.0001            
Class of Warrant or Right, Exercised in Period (in shares)           235,000          
Stock Issued During Period, Shares, Warrant Exercises (in shares)           235,000          
Jenkins Family Charitable Institute [Member] | Series H Warrants [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)         500,000            
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)         $ 1            
Jenkins Family Charitable Institute [Member] | Series I Warrants [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)         500,000            
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)         $ 1            
Jenkins Family Charitable Institute [Member] | Series J Warrants [Member]                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)         500,000            
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)         $ 1            
Class of Warrant or Right, Distributed (in shares)     450,000